Arine uses AI to optimize medication therapy, improving patient outcomes and reducing healthcare costs for payers and providers.
Arine has raised $30.0M in total funding. The most recent round was Series C. The last funding was announced in May 2025.
Arine's investors include MaC Venture Capital, Town Hall Ventures, Katalyst Ventures, Kaiser Permanente Ventures, SCAN Group.
Arine is headquartered in San Francisco, United States.
Arine uses AI to optimize medication therapy, improving patient outcomes and reducing healthcare costs for payers and providers.
Arine is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arine — Funding & Investors." VCBacked, May 16, 2025, https://www.vcbacked.co/company/arine. Accessed September 15, 2026.
VCBacked. (2025). Arine — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/arine
{{cite web |title=Arine — Funding & Investors |url=https://www.vcbacked.co/company/arine |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated